One-year soy isoflavone supplementation prevents early postmenopausal bone loss but without a dose-dependent effect

Published on Aug 1, 2006in Journal of Nutritional Biochemistry4.873
· DOI :10.1016/J.JNUTBIO.2006.01.003
Hui Ying Huang16
Estimated H-index: 16
(TMU: Taipei Medical University),
Hsiao-Ping Yang1
Estimated H-index: 1
(TMUH: Taipei Medical University Hospital)
+ 3 AuthorsShih Yi Huang25
Estimated H-index: 25
(TMU: Taipei Medical University)
Abstract It is believed that soy isoflavone has much potential effectiveness on the postmenopausal status; however, the optimal dose for preventing postmenopausal bone loss still remains unclear. This open-labeled, self-controlled pilot study was undertaken to determine the effect of 1-year supplementation of different high dosages of soy isoflavone in postmenopausal Taiwanese women. Forty-three women aged 45–67 years were enrolled and randomly assigned into a control (C), 100 mg/day isoflavone (IF100) and 200 mg/day isoflavone (IF200) groups for 1 year. Dual-energy X-ray absorptiometry and other related biochemical markers of bone metabolism were measured. Results indicated that the decrease in bone mineral density (BMD) was significant for lumbar vertebrae L1–3, L1–4 and the femur neck in the C group; surprisingly, the BMD of L1–3 was significantly elevated in the IF100 group; however, there were no consistent responses in the IF200 group. No significant change except loss of the bone mineral content of Ward's triangle (P=.003) was found in the IF200 group after treatment. The percentage change at L1–3 was less (P=.04) in the IF200 group when compared to the IF100 group. A relatively uniform direction of bone formation in expanding the weight and area with different rates of change resulted in different BMD changes. Both indicated a change of bone formation patterns with the higher-dose supplement. A protective effect of IF100 on estrogen-related bone loss was observed. A lack of a benefit such as high safety in the IF200 group for 1-year administration was ensured and lacked undesirable side effects.
📖 Papers frequently viewed together
129 Citations
161 Citations
239 Citations
#1Mei-Ling Ho (KMU: Kaohsiung Medical University)H-Index: 26
#2Tsen-Ni Tsai (KMU: Kaohsiung Medical University)H-Index: 1
Last. Chin Hsu (KMU: Kaohsiung Medical University)H-Index: 1
view all 6 authors...
Lack of mechanical stress may result in osteo- porosis; however, the underlying mechanisms of disuse osteoporosis remain unclear. It has been indicated that mechanical loading causes extracellular glutamate accu- mulation in osteoblasts. We hypothesized that the gluta- mate receptor mediation on bone cells might also be involved in mechanically stimulated osteogenesis. In this study, we investigated the changes of bone formation and the expressions of osteogenic genes and N-methyl D- aspartate (...
31 CitationsSource
Purpose of review Osteoporosis is a common disease with a strong genetic component characterised by reduced bone mass and an increased risk of fragility fractures. Several advances have been made over recent years in understanding the genetic basis of susceptibility to osteoporosis. This paper will review recent developments in this area. Recent findings Twin studies have shown that genetic factors contribute to osteoporosis by influencing bone mineral density and other determinants of fracture ...
113 CitationsSource
#1Connie M. Weaver (Purdue University)H-Index: 68
#2Jennifer M. K. Cheong (Purdue University)H-Index: 6
Evidence of the effect of purified soy isoflavones and soy protein isolates containing isoflavones on bone health in rats and in humans is inconsistent. Differences may be because of synergies or antagonisms among the isoflavones, threshold or biphasic dose effects, life stage of animals or human subjects, estrogen status, and environment-genetic interactions, including the ability to produce metabolites upon ingestion of isoflavones. At this time, the benefits of soy protein and isoflavones on ...
115 CitationsSource
#1Paul D. MillerH-Index: 63
#2Marc C. Hochberg (UMB: University of Maryland, Baltimore)H-Index: 120
Last. Richard D. WasnichH-Index: 43
view all 5 authors...
ABSTRACTMeasurements of bone mineral density (BMD) and biochemical markers of bone turnover are useful in the diagnosis and management of osteoporosis, as well as in research relating to the pathogenesis and treatment of the disease. Recent challenges to the utility of these measures have resulted in some confusion among both researchers and clinicians. BMD accounts for the great majority of bone strength and is the current gold standard for the diagnosis of osteoporosis, as well as for predicti...
90 CitationsSource
#1Bahram H. Arjmandi (OSU: Oklahoma State University–Stillwater)H-Index: 40
#2Edralin A. Lucas (OSU: Oklahoma State University–Stillwater)H-Index: 28
Last. Claudia Mason (OSU: Oklahoma State University–Stillwater)H-Index: 1
view all 9 authors...
Background Although soy protein and its isoflavones have been reported to reduce the risk of osteoporosis in peri- and post-menopausal women, most of these studies are of short duration (i.e. six months). The objective of this study was to examine if one year consumption of soy-containing foods (providing 25 g protein and 60 mg isoflavones) exerts beneficial effects on bone in postmenopausal women.
161 CitationsSource
#1Bolin Liu (University of Oklahoma Health Sciences Center)H-Index: 1
#2Susan M. Edgerton (OU: University of Oklahoma)H-Index: 17
Last. Ann D. Thor (OU: University of Oklahoma)H-Index: 69
view all 10 authors...
Wild-type erbB-2/ neu transgenic mice were used to study the interactions between tamoxifen and dietary phytoestrogens (or isoflavones) by dose and form in vivo . Mice were randomized to one of four dietary formulas and implanted with an 8-week continuous-release tamoxifen or placebo pellet at 8 weeks of age. In placebo-treated mice, soy meal diet (but not diets supplemented with low-dose or high-dose isoflavones or a casein diet) resulted in prolongation of tumor latency. In tamoxifen-treated m...
166 Citations
#1John A Robbins (UC Davis: University of California, Davis)H-Index: 77
#2Anne-Marie SchottH-Index: 41
Last. P. J. Meunier (French Institute of Health and Medical Research)H-Index: 63
view all 6 authors...
Hip fractures are common among older women. At the present time, major efforts are being made to identify women with low bone mineral density (BMD). However, more than half of hip fractures occur in women who would not classically be considered osteoporotic by BMD. This study aimed to identify factors associated with hip fracture in women with high BMDs. A total of 7598 French women aged over 74 participated in the EPIDOS study and had BMD measured by dual energy X-ray absorptiometry. Analysis w...
123 CitationsSource
#1Uwe Ullmann (DSM)H-Index: 1
#2Juergen MetznerH-Index: 1
Last. Christoph Riegger (DSM)H-Index: 6
view all 5 authors...
Genistein, an isoflavone and phytoestrogen predominantly found in soy, is considered a potentially safe therapeutic option to prevent postmenopausal bone loss. A novel purified product consisting of 99.4% synthetic genistein aglycone was investigated in a phase 1 clinical study to assess safety and tolerability in healthy volunteers as well as to obtain pharmacokinetic data. Single oral doses of 30, 60, 150, or 300 mg were administered to 40 healthy volunteers in this prospective, randomized, op...
52 CitationsSource
#1Laura S. Harkness (Case Western Reserve University)H-Index: 6
#2Karen Fiedler (MetroHealth)H-Index: 1
Last. Edith Lerner (Case Western Reserve University)H-Index: 12
view all 5 authors...
Objective: To investigate the effect of soy isoflavone supplementation on bone mineral density (BMD) and markers of bone turnover in postmenopausal women. Methods: In this randomized, placebo-controlled clinical trial, we used a crossover design to test the effect of soy isoflavone (110 mg/day) (1.3:1.0:0.22 ratio of genistein/daidzein/ glycitein) on bone formation, bone resorption, bone mineral content (BMC), and BMD for 6 months. Results: Postmenopausal women (n = 19), mean age 70.6 ± 6.3 year...
104 CitationsSource
#1U. Ulrich (University of Bonn)H-Index: 2
#2P. B. Miller (UW: University of Washington)H-Index: 2
Last. M. R. Soules (UW: University of Washington)H-Index: 2
view all 7 authors...
Introduction This study was designed to assess changes in biochemical markers of bone remodeling in early postmenopausal women receiving calcium supplementation.
4 CitationsSource
Cited By59
#1Zijun Xu (SJTU: Shanghai Jiao Tong University)
#2Huwen Wang (SJTU: Shanghai Jiao Tong University)H-Index: 5
Last. Yong Cai (SJTU: Shanghai Jiao Tong University)H-Index: 16
view all 10 authors...
The aim of this network meta-analysis is to compare bone mineral density (BMD) changes among different osteoporosis prevention interventions in postmenopausal women. We searched MEDLINE, Embase and Cochrane Library from inception to 24 February 2019. Included studies were randomised controlled trials (RCT) comparing the effects of different treatments on BMD in postmenopausal women. Studies were independently screened by six authors in three pairs. Data were extracted independently by two author...
#1Masoumeh Akhlaghi (Shiraz University of Medical Sciences)H-Index: 9
#2Maryam Ghasemi Nasab (Shiraz University of Medical Sciences)H-Index: 1
Last. Fatemeh Sadeghi (Shiraz University of Medical Sciences)H-Index: 4
view all 4 authors...
AbstractBackground: Osteoporosis is a common bone disease characterized by reduced bone mass resulting from continuous bone resorption.Methods: PubMed, Scopus, and Embase were searched to find publ...
9 CitationsSource
#1Eric Rochester (SDSU: San Diego State University)H-Index: 1
#2Brooke E. Wickman (SDSU: San Diego State University)H-Index: 1
Last. Shirin Hooshmand (SDSU: San Diego State University)H-Index: 18
view all 7 authors...
Phytoestrogens are nonsteroidal plant compounds with similar chemical structures to mammalian estrogen capable of mimicking the effect of estrogen in selective tissues. A diet rich in phytoestrogens is associated with a variety of health benefits including decreased risks for heart disease, breast cancer, and osteoporosis. Obesity has long thought to be associated with improved bone density due to increased mechanical loading, but recent literature suggests obesity may actually decrease bone hea...
3 CitationsSource
#1So Mi Kim (Hallym University)H-Index: 3
#2Hyun Sook Lee (Dongseo University)H-Index: 11
Last. Eun Ji Kim (Hallym University)H-Index: 25
view all 9 authors...
BACKGROUND/OBJECTIVE: There is intense interest in soy isoflavone as a hormone replacement therapy for the prevention of postmenopausal osteoporosis. A new kind of isoflavone-enriched whole soy milk powder (I-WSM) containing more isoflavones than conventional whole soy milk powder was recently developed. The aim of this study was to investigate the effects of I-WSM on bone metabolism in ovariectomized mice. MATERIALS/METHODS: Sixty female ICR mice individually underwent ovariectomy (OVX) or a sh...
3 CitationsSource
#1Max Norman Tandrup Lambert (Aarhus University Hospital)H-Index: 4
#2Lin Meng Hu (Aarhus University Hospital)H-Index: 1
Last. Per Bendix Jeppesen (Aarhus University Hospital)H-Index: 24
view all 3 authors...
: Background: Age-related estrogen deficiency leads to accelerated bone resorption. There is evidence that, through selective estrogen receptor modulation, isoflavones may exert beneficial effects against estrogen-deficient bone loss. Isoflavone aglycones show higher bioavailability than their glycosidic counterparts and thus may have greater potency.Objective: To summarize evidence, we executed a systematic review and meta-analysis examining isoflavone therapies and bone mineral density (BMD) l...
26 CitationsSource
#1Masumeh Ghazanfarpour (MUMS: Mashhad University of Medical Sciences)H-Index: 8
#2Elham Amini (MUMS: Mashhad University of Medical Sciences)H-Index: 1
Last. Maliheh Afiat (MUMS: Mashhad University of Medical Sciences)H-Index: 4
view all 7 authors...
Objectives: The present trial aimed to assess the effects of Fennel (Foeniculum vulgare Mill.) on lipid profiles. Methods: In this double blind, randomized and placebo-controlled trial, sixty eligible postmenopausal women were randomly assigned into the fennel and placebo groups. Total blood cholesterol, cholesterol fractions, and triglycerides were tested at the baseline, and after three-month follow-up. Results: There was no significant difference in triglyceride (P = 0.679), total cholesterol...
7 CitationsSource
#1Hye-Jin Ahn (Kyung Hee University)H-Index: 6
#2Yoo Kyoung Park (Kyung Hee University)H-Index: 17
Abstract Objectives The aim of this study was to investigate the effects of soy isoflavone on tibia length, bone mineral density (BMD), and structural parameters in growing female rats. Methods Three-week-old female Sprague-Dawley rats were randomly assigned to four experimental groups: control (CON: distilled water gavage); low-dose isoflavone (low-IF: 10 mg/kg body weight [BW]/d gavage); high-dose isoflavone (high-IF: 50 mg/kg BW/d gavage); and 17 β-estradiol (E2: subcutaneous injection of 10 ...
5 CitationsSource
#1Fatemeh Abdi (Shahid Beheshti University of Medical Sciences and Health Services)H-Index: 9
#2Zainab Alimoradi (Shahid Beheshti University of Medical Sciences and Health Services)H-Index: 8
Last. F Mahdizad (Shahid Beheshti University of Medical Sciences and Health Services)H-Index: 1
view all 4 authors...
AbstractIntroduction: Menopause is associated with increased bone resorption and decreased bone mineral density (BMD). Phytoestrogens are believed to prevent bone loss. This study reviewed relevant randomized, controlled trials to determine the effects of phytoestrogens on BMD in postmenopausal women.Methods: In order to perform this systematic review, PubMed, Science Direct, Scopus, Cochrane Library, ISI Web of Knowledge, and ProQuest databases were searched for articles published during 2005–2...
27 CitationsSource
#1Xi Zheng (UConn: University of Connecticut)H-Index: 1
#2Sun-Kyeong Lee (University of Connecticut Health Center)H-Index: 31
Last. Ock K. Chun (UConn: University of Connecticut)H-Index: 35
view all 3 authors...
Abstract Osteoporosis is an age-related disorder that affects both women and men, although estrogen deficiency induced by menopause accelerates bone loss in older women. As the demographic shifts to a more aged population, a growing number of men and women will be afflicted with osteoporosis. Since the current drug therapies available have multiple side effects, including increased risk of developing certain types of cancer or complications, a search for potential nonpharmacologic alternative th...
62 CitationsSource
Soy isoflavones, genistein, daidzein and its metabolite equol, as well as β-carotene have been reported to be effective for maintaining bone health. However, it remains to be elucidated whether combining soy isoflavones with β-carotene is beneficial to bone formation. This study investigated the combined effect of soy isoflavones and β-carotene on the differentiation of MC3T3-E1 preosteoblastic cells. Daidzein and genistein alone did not affect cell growth but increased alkaline phosphatase (ALP...
14 CitationsSource